Jubilee Field Phase 1 definition

Jubilee Field Phase 1 means the Phase 1 development of the Jubilee Field, as described in the Phase 1 Plan of Development for the Jubilee Field, including the Project Infrastructure and all appraisal, exploration, construction, operations, maintenance and exploitation works and activities, and the treatment, processing, storage, delivery, lifting and sale of Unit Substances therefrom.
Sample 1Sample 2Sample 3

Examples of Jubilee Field Phase 1 in a sentence

  • Norway’s Ministry of the Environment in 2008 provided advice to the EPA on the planning of the Jubilee field Environmental Impact Assessment (EIA); and in the following year provided comments to the Jubilee Field Phase 1 Development EIS Review.

  • Xxxxx, Director, Chief Financial Officer and Principal Accounting Officer To you: 00 Xxxxxxxx Xxxxx Xxxxxxxxxxxx, XX 00000 or to such other address, facsimile number, or email address, as is specified by a party by notice to the other party given in accordance with the provisions of this Paragraph 16.

  • Non-STCW but important training areas, where simulator could play an important role e.g.:• ECDIS• HSC• Integrated bridge• Human Factor related.The gaps and shortcomings are summarised in a report and used to define the follow-up actions for WP 5, where additional training scenarios were set up.

  • Tullow Ghana Limited, (2009) “Ghana Jubilee Field Phase 1 Development: Draft Environmental Impact Statement”, p.

  • The Jubilee Field Phase 1 development location was defined based on the geophysical seismic survey data and subsequent exploration and appraisal well drilling results to date.

  • This chapter provides an assessment of potential environmental and social impacts from the Jubilee Field Phase 1 Development project.

  • Sources of Impact The Jubilee Field Phase 1 development will have a physical footprint on the seabed through placement of infrastructure during the construction and commissioning of subsea infrastructure and from the permanent presence of some of this infrastructure.

  • In short, the MPA together with our observations of relations between the GNPC, the contractors and the operators (Tullow, Kosmos and Anadarko) on the Jubilee Field Phase 1 show that current Ghanaian petroleum agreements is of a hybrid type.

  • Keeping in view the above, it is suggested that the Health checkup facility should be provided in a routine manner basing on the deployment of the machine programme i.e. where 10 (Ten) nos or above Track Machines are deployed to work at a time for, At that spot only the Medical Authority of that Division have to extended the Health checkup facilities to them.

  • A total of 17 development wells have been drilled during the Jubilee Field Phase 1 development.

Related to Jubilee Field Phase 1

  • Development Phase means the period before a vehicle type is type approved.

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase I Trial means a clinical trial of a Licensed Product in human patients designated as a Phase I Trial and conducted primarily for the purpose of determining the safety of and/or the metabolism and pharmacologic actions of the Licensed Product in humans, as described under 21 CFR § 312.21(a) (as hereafter modified or amended) and any of its foreign equivalents. For purposes of this definition, Phase I Trial shall specifically exclude trials in healthy volunteers.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Development Area means that area to which a development plan is applicable.

  • Phase 1 means the first implementation phase of this section, beginning June 1, 2018 and ending May 31, 2022.

  • Final Product means a product that is not used in producing other products and is built and intended for use outdoors, provided the final product has not deteriorated or has otherwise become a potential source of contaminants.

  • Development Project means a project for the development of land within a

  • Phase III Clinical Study means a pivotal Clinical Study, the results of which could be used to establish safety and efficacy of a Licensed Product in the Field as a basis for Regulatory Approval or that would otherwise satisfy requirements of 21 CFR 312.21(c), or its foreign equivalent.